Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?
Sisli Hamidiye Etfal Training and Research Hospital
· 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
childhood
na
obesity
obesity, childhood, nafld, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Acupuncture for Heel Pain Syndrome
#1033717
Results of Endoscopic Sinus Surgery in Management of Ophthalmological Complications of Chronic Rhino Sinusitis
#1033721
Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients
#1033724
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Record
· ID 860526
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.